SFG Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
SFG Wealth Management's PFE Position: Q1 2026 in Review
SFG Wealth Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 11,385 shares — an estimated $283K sold.
SFG Wealth Management first reported a position in PFE in Q4 2021 and held it in 7 quarters. The position peaked at $367K in Q3 2025. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- SFG Wealth Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- SFG Wealth Management sold 11,385 Pfizer shares in Q1 2026, an estimated $283K.
- SFG Wealth Management first reported a position in Pfizer in Q4 2021 and held it in 7 quarters.
- SFG Wealth Management's Pfizer position peaked at $367K in Q3 2025.
- 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on SFG Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.